Abstract
Well-differentiated liposarcoma (WDL) is one of the most common soft tissue sarcomas in adults. It has a predilection for middle-aged males and arises in deep-seated locations such as retroperitoneum, mediastinum, and spermatic cord. Its occurrence in young individuals at the hypopharyngeal region is an exceedingly rare event. Myxoid liposarcoma (ML)-like changes can seldom occur in some cases of WDL, which makes the diagnosis of WDL more challenging. Amplification of DDIT3 gene in a subset of cases of WDL has shown to be associated with such unique morphology. Herein, we present a case of a 36-year-old gentleman who presented with difficulty in breathing and swallowing for 3 months duration. CT scan of the neck revealed a lesion along the posterior wall of the hypopharynx measuring 3.5 cm. Histopathologic examination revealed a tumor composed of lobules of oval to spindle cells in a prominent myxoid stroma with delicate chicken-wire vasculature. In the vicinity, there were lobules composed of variably sized adipocytes separated by thick fibrous septa that contains atypical hyperchromatic spindle cells. By immunohistochemistry, the tumor cells in both components were immunoreactive for CDK4, but negative for MDM2. Fluorescence in-situ hybridization (FISH) confirmed the presence of MDM2 gene amplification. There was no evidence of FUS-DDIT3 gene rearrangement, however, DDIT3 gene was also amplified. The diagnosis of well-differentiated liposarcoma with prominent myxoid stroma was rendered. This is the first documentation of WDL with ML-like morphology harboring co-amplification of MDM2 and DDIT3 in the hypopharynx.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Liposarcomas are the most common type of sarcomas in adults [1,2,3]. They are divided into four main subtypes: atypical lipomatous tumor/well-differentiated liposarcoma (WDL), myxoid liposarcoma (ML), pleomorphic liposarcoma and dedifferentiated liposarcoma (DDL). ATL/WDL has predilection for middle-aged adults in the fourth and fifth decade [1,2,3]. Its occurrence in individuals younger than 40 years-old is uncommon [3]. ATL is the preferred terminology for tumors that arise at sites amenable to surgical resection such as the extremities and trunk, though WDL is the terminology used for tumors at deep-seated locations such as the retroperitoneum and mediastinum [1,2,3]. Hypopharyngeal/laryngeal liposarcomas are exceedingly rare [4,5,6,7,8,9,10]. Most reported cases are of well-differentiated or de-differentiated types [4,5,6,7,8,9,10]. Occasionally, some liposarcomas show combined morphologic features of two or more subtypes [1, 2]. In such cases, cytogenetic testing is the gold standard method for categorization of the tumor into one of these main subtypes. WDL is characterized by amplification of q13-15 region of chromosome 12, whereas ML is characterized mainly by FUS-DDIT3 gene fusion [11,12,13]. Herein, we present a case of liposarcoma arising in the hypopharynx that showed combined morphologic features of WDL and ML in a 36-year-old man. The diagnosis was reached by performing cytogenetics studies. The tumor showed MDM2 gene amplification, and eventually was categorized as well-differentiated liposarcoma. Interestingly, DDIT3 gene amplification was also detected. To the best of our knowledge, this is the first case of hypopharyngeal WDL that exhibits ML-like morphology with MDM2 and DDIT3 co-amplification.
Case Presentation
Clinical Findings
A 36-year-old gentleman presented to the outpatient clinic with difficulty of breathing and swallowing for 3 months duration. Fiberoptic examination revealed a smooth mobile swelling arising from the right hypopharyngeal wall protruding into the larynx and causing partial airway obstruction. Computed Tomography (CT) scan of the neck revealed a 3.5 cm well-defined cystic-like lesion with clear fluid density contents along the posterior wall of the hypopharynx, encroaching upon the hypopharyngeal airway and right piriform fossa, with extension into the supra-laryngeal space (Fig. 1). It showed no enhancement on post-contrast series. The overall radiologic features were favoring a benign neoplasm/lesion, and the differential diagnosis included fibroepithelial and lymphangiomatous polyp. Hypopharyngeoscopy with mass excision was carried out.
Histopathology and Immunohistochemistry
Macroscopic examination of the resected specimen revealed a pedunculated rubbery nodule measuring 3.5 cm in maximum dimension. Cut sections showed lobulated dull rubbery and focally shiny gelatinous surfaces (Fig. 2). Microscopic examination showed squamous mucosa with underlying submucosal tumor composed of lobules of atypical oval to spindle non-lipogenic cells in a prominent myxoid stroma with arborizing chicken-wire vasculature (Figs. 3A-E). In the vicinity, there were lobules of adipose tissue separated by thick fibrous septa containing atypical hyperchromatic spindle cells (Figs. 3F-G). No definite lipoblasts were seen. There was no evidence of necrosis. Mitotic rate was 2 per 10 high-power fields (HPFs). The tumor was extending to the resection margin. Immunohistochemical studies using primary antibodies for MDM2 (clone SMP14, Zeta, dilution 1/230) and CDK4 (clone DCS-31, Zeta, dilution 1/230) revealed that the tumor cells in both components were immunoreactive for CDK4 (Fig. 4A). However, staining for MDM2 antibody was negative (Fig. 4B).
Cytogenetics
FISH analysis was performed on 4-μm-thick sections from formalin-fixed paraffin-embedded tissue (FFPE). A representative FFPE block that contains tumor with both morphologies was selected. The testing was performed using Vysis MDM2 (12q15)/CEP12(D12Z3) FISH Probe Kit (Abbott laboratories, Illinois, U.S.A), and DDIT3 (12q13) Break Apart Probe (Mayo clinic laboratories, Minnesota, U.S.A). MDM2 gene amplification was detected with MDM2:D12Z3 ratio of 22.3. No rearrangement of the DDIT3 probe was observed. However, amplification of DDIT3 probe region (at 12q13) was seen in all the 100 nuclei examined [100/100]. Testing for FUS and EWSR1 gene rearrangement was also performed using Vysis LSI FUS Break Apart FISH Probe Kit (Abbott laboratories, Illinois, U.S.A) and Vysis LSI EWSR1 Break Apart FISH Probe Kit (Abbott laboratories, Illinois, U.S.A). Neither FUS nor EWSR1 gene rearrangement were detected.
Diagnosis and Clinical Course
Based on the immunohistochemistry and cytogenetics results, the diagnosis of well-differentiated liposarcoma with prominent myxoid stroma was rendered. The postoperative course was uneventful. Magnetic Resonance Imaging (MRI) of the neck with contrast performed 6 months post-discharge, showed no evidence of residual tumor or local recurrence. The patient will be followed up after 12 and 24 months to look for any signs of local recurrence or distant metastasis.
Discussion
Well-differentiated liposarcoma rarely arise at the head and neck region. Its occurrence in the hypopharynx is exceedingly rare with approximately 40 cases reported in the literature [4,5,6,7,8,9,10]. Complete surgical resection is difficult to achieve at this site, therefore, the clinical course of hypopharyngeal WDL is typically characterized by multiple local recurrences, however, distant metastasis has not been reported [4,5,6,7,8,9,10]. Few cases had been described to undergo dedifferentiation after recurrence [5, 6, 10]. Hypopharyngeal WDL has predilection for middle aged males and uncommonly arise in individuals younger than 40 years [3,4,5,6,7,8,9,10]. In our case, the patient was only 36 years old, which is a rather unusual finding.
It has been shown that some cases of WDL may have prominent myxoid stroma, which makes its distinction from myxoid liposarcoma very challenging [2]. It is essential to differentiate between WDL with prominent myxoid changes from ML, as both tumors have different prognosis and treatment. ML tends to metastasize more often than WDL, unless the latter is associated with a dedifferentiated component [1, 2]. ML is more sensitive to radiotherapy and chemotherapeutic agents, whereas WDL can be curable with complete surgical resection [1, 2].
Morphologically, WDL is subdivided into adipocytic (lipoma-like) and sclerosing subtypes. Lipoma-like subtype is composed of mature adipocytes of variable sizes with scattered atypical hyperchromatic cells, whereas in the sclerosing subtype, adipocytes are separated by thick fibrous bands that contain spindle cells with atypical hyperchromatic nuclei. ML is characterized by having less adipocytic component and mainly composed of small ovoid monomorphic cells with minimal atypia, delicate arborizing capillaries “chicken-wire vasculature” and prominent mucoid stroma. In our case, some areas had ML-like morphology while other areas showed classic morphology of the sclerosing subtype of WDL. In both components, there was a degree of nuclear atypia in the tumor cells, a feature favoring the diagnosis of WDL. However, it was difficult to reach a definitive diagnosis based on histomorphology alone.
Ancillary testing by immunohistochemistry and cytogenetic studies can aid in making the distinction between both entities. FUS-DDIT3 gene fusion, and less commonly, EWSR1-DDIT3 are diagnostic for ML [1, 2, 13], whereas the presence of 12q13-15 amplification involving MDM2/CDK4 genes would confirm the diagnosis of WDL [1, 2, 11, 12]. Detection of MDM2 and CDK4 protein expression can be achieved by immunohistochemistry [1, 2, 11]. In our case, the tumor cells were diffusely positive for CDK4 but negative for MDM2. We would like to emphasize here that negative staining for MDM2 does not rule out the diagnosis of WDL, as immunohistochemistry is a less sensitive method than FISH for detection of MDM2 gene amplification [1, 2, 11, 12]. It has also been found that DDIT3 expression by immunohistochemistry can aid in the evaluation of lipomatous tumors, especially those that exhibit myxoid morphology [14]. Diffuse moderate to strong nuclear positivity for DDIT3 would support the diagnosis of ML. However, this antibody was not available in our facility. The case had been sent for FISH analysis, which confirmed the presence of MDM2 gene amplification in our case. No FUS or EWSR1 gene rearrangement were detected, and the overall findings were diagnostic of WDL.
Other diagnostic considerations in our case include atypical spindle cell/pleomorphic lipomatous tumor (ASPLT) and low-grade DDL. ASPLT is an ill-defined tumor composed of mixture of adipocytes, lipoblasts, spindle cells with mild to moderate atypia and pleomorphic multinucleated giant cells [1, 15]. The tumor is typically negative for MDM2 and CDK4 or show only focal weak staining, with consistent absence of MDM2 and CDK4 amplification [1, 15]. DDL is characterized by abrupt transition from WDL to non-lipogenic sarcoma, which is high-grade in most cases [1, 16, 17]. However, low-grade variants of DDL with homologous lipoblastic differentiation had been described [16]. Low-grade DDL is formed by low-grade spindle cell sarcoma with immature adipocytic component. Typically, it shows consistent diffuse nuclear reactivity for MDM2 and/or CDK4 with invariable MDM2 amplification by FISH [1, 16]. This variant can be associated with prominent myxoid stroma. When that occurs, the distinction from WDL with ML-like morphology becomes extremely difficult. It has been found that the main distinguishing features between low-grade DDL and WDL are cellularity and mitotic rate [16, 17]. Low-grade DDL typically shows moderate cellularity and at least 5 mitoses/10 HPFs [16], while cellularity in WDL is lower and mitotic figures are rare. In our case, the cellularity was low and mitotic rate was only 2/10 HPFs, which excluded the possibility of low-grade DDL.
Interestingly, DDIT3 gene amplification by FISH was also detected in our case. DDIT3 gene is located on 12q13.2, a region very proximate to the MDM2 and CDK4 genes [18, 19]. Due to this geographic proximity, DDIT3 gene can be amplified in a subset of cases of WDL and dedifferentiated liposarcoma. DDIT3 encodes for a nuclear protein in the CCAAT/enhancer-binding protein (C/EBP) family, and functions as a transcription factor that plays a role in adipogenesis and adipocytic differentiation [18,19,20,21]. It has been shown in some studies that DDIT3 gene amplification is associated with myxoid liposarcoma-like morphology [18, 19]. Mantilla et al. evaluated the presence of DDIT3 amplification in 48 cases of de-differentiated liposarcoma and found that 33% of the cases had DDIT3 amplification, of those, 75% were associated with ML-like morphology [18]. Therefore, DDIT3 gene amplification may explain the presence of ML-like morphology in our case. However, the clinical and prognostic value of this finding is still not well understood.
In summary, WDL of the hypopharynx is rare and exceptional in young individuals. Some cases of WDL can have prominent myxoid stroma and features resembling ML. Immunohistochemistry and cytogenetic studies are essential to reach a definitive diagnosis in such cases. DDIT3 gene amplification has shown to be associated with ML-like changes in few studies, which may also explain this unique morphology in our case. This the first documentation of WDL with ML-like morphology in the hypopharynx with MDM2 and DDIT3 co-amplification.
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
WHO Classification of Tumours Editorial Board. WHO Classification of Tumours of Soft Tissue and Bone. 5th ed. Lyon, France: IARC Press; 2020.
Sioletic S, Dal Cin P, Fletcher CD, Hornick JL. Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases. Histopathology. 2013;62:287–93.
Waters R, Horvai A, Greipp P, John I, Demicco EG, Dickson BC, Tanas MR, Larsen BT, Ud Din N, Creytens DH, Bahrami A, Doyle LA, Jo VY, Al-Ibraheemi A, Thway K, Jenkins SM, Siontis B, Folpe A, Fritchie K. Atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma in patients aged ≤ 40 years: a study of 116 patients. Histopathology. 2019;75(6):833–42.
Wenig BM, Weiss SW, Gnepp DR. Laryngeal and hypopharyngeal liposarcoma. A clinicopathologic study of 10 cases with a comparison to soft-tissue counterparts. Am J Surg Pathol. 1990;14(2):134–41.
Wenig BM, Heffner DK. Liposarcomas of the larynx and hypopharynx: a clinicopathologic study of eight new cases and a review of literature. Laryngoscope. 1995;105:747–56.
Makeieff M, Pelliccia P, Poizat F, Arnaud S, Rat F, Cupissol D, Guerrier B, Costes V. Laryngeal dedifferentiated liposarcoma. Eur Arch Otorhinolaryngol. 2010;267(6):991–4.
Corvino A, Riva G, Sensini M, Garzaro M, Pecorari G. Liposarcomas of the hypopharynx: a systematic review of the literature. J Health Soc Sci. 2016;1(1):57–66.
Riva G, Sensini M, Corvino A, Garzaro M, Pecorari G. Liposarcoma of hypopharynx and esophagus: a Unique Entity? J Gastrointest Cancer. 2016;47(2):135–42.
Zhu H, Sun J, Wei S, Wang D, Brandwein M. Well-Differentiated laryngeal/hypopharyngeal liposarcoma in the MDM2 era report of three cases and literature review. Head Neck Pathol. 2017;11(2):146–51.
Fritchie K, Ghosh T, Graham RP, Roden AC, Schembri-Wismayer D, Folpe A, Rivera M. Well-differentiated/dedifferentiated liposarcoma arising in the upper aerodigestive tract: 8 cases mimicking non-adipocytic lesions. Head Neck Pathol. 2020;14(4):974–81.
Binh MB, Sastre-Garau X, Guillou L, de Pinieux G, Terrier P, Lagacé R, Aurias A, Hostein I, Coindre JM. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol. 2005;29(10):1340–7.
Weaver J, Downs-Kelly E, Goldblum JR, et al. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol. 2008;21(8):943–9.
Yu JSE, Colborne S, Hughes CS, Morin GB, Nielsen TO. The FUS-DDIT3 Interactome in Myxoid Liposarcoma. Neoplasia. 2019;21(8):740–51.
Scapa JV, Cloutier JM, Raghavan SS, Peters-Schulze G, Varma S, Charville GW. DDIT3 immunohistochemistry is a useful tool for the diagnosis of myxoid liposarcoma. Am J Surg Pathol. 2021;45(2):230–9.
Lecoutere E, Creytens D. Atypical spindle cell/pleomorphic lipomatous tumor. Histol Histopathol. 2020;35(8):769–78.
Liau JY, Lee JC, Wu CT, Kuo KT, Huang HY, Liang CW. Dedifferentiated liposarcoma with homologous lipoblastic differentiation: expanding the spectrum to include low-grade tumours. Histopathology. 2013;62(5):702–10.
Henricks WH, Chu YC, Goldblum JR, Weiss SW. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol. 1997;21:271–81.
Mantilla JG, Ricciotti RW, Chen EY, Liu YJ, Hoch BL. Amplification of DNA damage-inducible transcript 3 (DDIT3) is associated with myxoid liposarcoma-like morphology and homologous lipoblastic differentiation in dedifferentiated liposarcoma. Mod Pathol. 2019;32(4):585–92.
Rao UN, Cieply K, Sherer C, Surti U, Gollin SM. Correlation of classic and molecular cytogenetic alterations in soft-tissue sarcomas: analysis of 46 tumors with emphasis on adipocytic tumors and synovial sarcoma. Appl Immunohistochem Mol Morphol. 2017;25:168–77.
Engström K, Willén H, Kåbjörn-Gustafsson C, Andersson C, Olsson M, Göransson M, Järnum S, Olofsson A, Warnhammar E, Aman P. The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells. Am J Pathol. 2006;168(5):1642–53.
Kåbjörn Gustafsson C, Engström K, Aman P. DDIT3 expression in liposarcoma development. Sarcoma. 2014. https://doi.org/10.1155/2014/954671.
Acknowledgements
We would like to express our special thanks to Professor Christopher Fletcher, Brigham and Women’s Hospital, Boston, for reviewing this challenging case. We would like also to thank Dr. Einas Al-Kuwari, the chairperson of DLMP at Hamad Medical Corporation, for her support.
Funding
Open access funding provided by the Qatar National Library.
Author information
Authors and Affiliations
Contributions
KAM wrote the first draft of the manuscript and performed literature review, HAS assisted in manuscript writing, provided micrographs, and reviewed the manuscript. AA contributed to study conception and reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
None to declare.
Ethical Approval
The Institutional Review Board at Hamad Medical Corporation approved publication of this article under the number (MRC-04–21-398).
Consent to Publish
Informed consent from the participant has been waived by Institutional Review Board.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Murshed, K.A., Abo Samra, H. & Ammar, A. Well-Differentiated Liposarcoma of the Hypopharynx Exhibiting Myxoid Liposarcoma-like Morphology with MDM2 and DDIT3 Co-Amplification. Head and Neck Pathol 16, 288–293 (2022). https://doi.org/10.1007/s12105-021-01341-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12105-021-01341-5